COMMENTARY ARTICLE
AI-driven strategies, which have emerged in diverse high-tech fields over the past few years, are now reshaping supply chains in pharmaceuticals, healthcare, chemicals, and biotechnology by placing sustainability and human well-being at the forefront. Over the course of the early twenty-first century, rapid strides in data-centric technologies and refined metrics for environmental, social, and governance (ESG) considerations have opened up new possibilities for optimizing everything from R&D processes to large-scale manufacturing and global distribution. The pages that follow offer cross-industry perspectives through different panel discussions on how AI and ESG principles are evolving, and how they might define the future of sustainable operations across various sectors.
